A nationwide seroepidemiology of hepatitis C virus infection in South Korea
- 3 January 2013
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 33 (4) , 586-594
Abstract
Background & Aims: The aim of this study was to reveal nationwide seroprevalence of HCV infection in South Korea by a large‐scale survey.Methods: From January to December 2009, a total of 291 314 adults underwent health check‐up in 29 centres nationwide. The data concerning anti‐HCV antibody and biochemical tests were obtained from all participants. Among subjects with positive anti‐HCV, such data as HCV RNA, genotypes and treatment detail were additionally analysed.Results: Using an estimated 2009 population of Korea, the age, sex and area‐adjusted anti‐HCV positive rate was 0.78%. Anti‐HCV prevalence in female patients (0.83%) was higher than that in male patients (0.75%). Gradual increase in anti‐HCV positivity was observed, from 0.34% in those aged 20–29 years to 2.31% in those >70 years. The age‐ and sex‐adjusted anti‐HCV prevalence varied in different areas, being higher in Busan and Jeonnam (1.53–2.07%), mid‐level in Seoul and surrounding districts (0.50–0.61%) and lower in Jeju (0.23%). The comparative analysis of laboratory variables between anti‐HCV (+) and anti‐HCV (−) group revealed significantly higher levels of alanine aminotransferase and lower levels of serum lipids in anti‐HCV (+) group. Among 1 718 anti‐HCV positive subjects, serum HCV RNA was measured only in 478 people, of whom 268 (56.1%) patients had detectable HCV RNA in serum. Among 50 patients for whom assessment of response to antiviral therapy was feasible, overall sustained virological response was achieved in 84% of patients.Conclusion: The prevalence of HCV infection is low in South Korea. Studies to analyse risk factors are warranted to reduce HCV infection.Keywords
Funding Information
- Merck Sharp & Dohme Corporation
This publication has 32 references indexed in Scilit:
- Prevalence of Hepatitis C Virus Infections and Distribution of Hepatitis C Virus Genotypes among Korean Blood DonorsAnnals of Laboratory Medicine, 2012
- Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational StudyGut and Liver, 2012
- Upper Limits of Normal for Alanine Aminotransferase Activity in the United States PopulationHepatology, 2011
- Directly acting antivirals against hepatitis C virusJournal of Antimicrobial Chemotherapy, 2011
- Hepatitis C pharmacogenetics: State of the art in 2010Hepatology, 2010
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease ProgressionGastroenterology, 2010
- Hepatitis C Virus Infection and Its Clearance Alter Circulating LipidsHepatology, 2009
- Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural EgyptGut, 2007
- Rate and predictors of treatment prescription for hepatitis CGut, 2006
- Thyroid Disorders in Chronic Hepatitis C Virus InfectionThyroid®, 2006